- Story /
Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
- Featured News /
Standing by people with sickle cell disease and their families
- Story /
Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.
- Story /
Alexandra Bach-Weidmuller, Head of Program and Project Management at NIBR, describes her path to leadership as lateral instead of upward.
- Story /
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
- Story /
Zebrafish imaging sheds light on human neurological conditions.
- Story /
Jean Silveri shares key insights from her legal career.
- Media Release /New data from the Phase 3 ASCLEPIOS I/II trials and ALITHIOS open-label extension show that after four years nearly 8 out of 10 of people with relapsing multiple sclerosis (RMS) treated continuously…
- Media Release /Approvals based on data from the JUNIPERA trial, showing that Cosentyx® (secukinumab) reduced the risk of flare and disease activity compared to placebo over 2 years in pediatric patients1 with…
- Story /
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
Pagination
- ‹ Previous page
- 1
- …
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- …
- 265
- › Next page